Fractus Sues ResMed Over Patent Infringement in Sleep Device Technologies
- Fractus has filed a patent infringement lawsuit against ResMed over connected sleep apnea devices.
- The lawsuit accuses ResMed of violating multiple Fractus patents related to high-performance antennas.
- Fractus seeks to protect its innovations and promote fair licensing in the digital health sector.
Fractus Initiates Legal Action Against ResMed Over Patent Infringement in Sleep Devices
Fractus, a leading innovator in geometry-based antenna technology, has launched a patent infringement lawsuit against ResMed, targeting the company’s connected sleep apnea devices. Filed in the U.S. District Court for the Southern District of California, the lawsuit (case number 3:25-cv-02680-LL-JLB) accuses ResMed of violating several of Fractus's patents that pertain to miniaturized, high-performance multi-band antennas. This legal action sheds light on the ongoing battle over intellectual property rights in the rapidly growing digital health sector, particularly as connected devices become increasingly essential for remote patient monitoring.
Fractus CEO Jordi Ilario underscores the importance of protecting intellectual property to ensure a fair competitive landscape for innovators. He notes that Fractus has invested decades into research aimed at delivering reliable wireless connectivity across various sectors, including healthcare. Ilario's comments reflect a broader concern within the tech industry about safeguarding inventions that drive innovation. Similarly, Ruben Bonet, Executive Chairman of Fractus, emphasizes the rising importance of robust connectivity solutions in digital health, indicating that their innovations are crucial for technology leaders who depend on reliable licensed technologies to enhance patient care.
The legal team representing Fractus, comprised of experienced trial lawyers from Kobre & Kim LLP, aims to uphold the company's rights while fostering innovation in the technology space. With a portfolio of over 40 patented inventions, Fractus’s technology is not only integral to smartphones and IoT devices but also plays a significant role in enhancing connected health applications. The company has earned accolades such as being named a Technology Pioneer by the World Economic Forum and receiving the "European Inspiring Company Award," further establishing its reputation as a leader in antenna design. Through this lawsuit, Fractus seeks to deter unauthorized usage of its innovations and reinforce the importance of intellectual property rights in the tech industry.
In light of the ongoing litigation, the stakes are high for both companies. As the demand for connected health solutions continues to rise, the outcome of this case could have implications for the development and deployment of new technologies in the healthcare sector. Fractus aims to protect its innovations while allowing other technology leaders to build upon its advancements through fair licensing agreements.
Related Cashu News

Merit Medical Systems Launches Employee Stock Ownership Plan to Boost Engagement and Stability
Merit Medical Systems (Ticker: MMSI) recently takes a significant step in enhancing its employee engagement and ownership structure with the launch of a new Employee Stock Ownership Plan (ESOP). The c…

Brookdale Senior Living launches second season of educational podcast "The Grey Take.
Brookdale Senior Living (Ticker: BKD) launches the second season of its popular podcast, "The Grey Take," which serves as a valuable resource for families exploring senior living options. The podcast…

Molina Healthcare Gains Momentum with Increased Risk Adjustment Payments and Positive Revenue Outlook
Molina Healthcare (Ticker: MOH) is making significant strides in its revenue outlook due to recently released risk adjustment figures from the Centers for Medicare & Medicaid Services (CMS). These upd…

Align Technology Faces Antitrust Investigation by European Commission Over Competitive Practices
Align Technology Inc. (Ticker: ALGN) faces a formal antitrust investigation from the European Commission, marking a significant development in the medical devices sector. This inquiry arises from a co…

